Cleared Traditional

K182757 - Espire Elbow Pro

K182757 is the FDA 510(k) clearance for Espire Elbow Pro by College Park Industries, Inc.. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K182757 · College Park Industries, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
62d
Days
Class 2
Risk

K182757 is an FDA 510(k) clearance for the Espire Elbow Pro, Espire Elbow Hybrid. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by College Park Industries, Inc. (Warren, US). The FDA issued a Cleared decision on November 29, 2018 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all College Park Industries, Inc. devices

Submission Details

510(k) Number K182757 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2018
Decision Date November 29, 2018
Days to Decision 62 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
86d faster than avg
Panel avg: 148d · This submission: 62d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Emergo Global Consulting, LLC
Ken Pilgrim

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 141
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K182757.
DAEHAN Disposable CUP Electrodes
K180232 · Daehan Medical Systems Co., Ltd. · Apr 2019
SM Electrodes
K183154 · Hong Qiangxing (Shenzhen) Electronics Limited · Mar 2019
DL Self-adhesive Electrode
K182111 · Shaoxing DL Healthcare Co., Ltd. · Jan 2019
DAEHAN Adhesive Surface Electrodes
K180247 · Daehan Medical Systems Co., Ltd. · Nov 2018
Sense System with IBT Electrodes
K182112 · Infinite Biomedical Technologies, LLC · Oct 2018
Self-adhesive Electrode
K181234 · Dong Guan OU Kang Electronics Co., Ltd. · Aug 2018